Drug-eluting stents.
Coronary artery disease (CAD) is currently a leading cause of death worldwide. Drug-eluting stents (DESs) have been dominant for the treatment of CAD in the interventional cardiology world owing to their efficacy in significantly reducing restenosis. However, late stage stent thrombosis has become a major concern. Stent platform, drug delivery vehicle and type of drug are three parts of DES and each part affects the performance of the DES. Aiming to provide a clue for the design of future DES, this review focuses on the development of the three major components of DES and their roles in restenosis and thrombosis.
Ma
Xiaodong
X
Wu
Tim
T
Robich
Michael P
MP
Wang
Xingwei
X
Wu
Hao
H
Buchholz
Bryan
B
McCarthy
Stephen
S
J Am Coll Cardiol. 2005 May 17;45(10):1574-9
15893169
N Engl J Med. 2007 Mar 8;356(10):1009-19
17296822
N Engl J Med. 1994 Aug 25;331(8):489-95
8041413
EuroIntervention. 2007 May;3(1):158-61
19737702
Lancet. 2008 Mar 15;371(9616):899-907
18342684
J Res Natl Inst Stand Technol. 2003 Jun 01;108(3):167-82
27413603
Pathol Biol (Paris). 2004 May;52(4):196-205
15145132
EuroIntervention. 2006 May;2(1):113-5
19755245
Circ Res. 2006 Jul 21;99(2):149-55
16794185
Pharmacol Res. 2008 Mar;57(3):171-80
18339557
J Biol Chem. 2002 Aug 30;277(35):32124-32
12052830
N Engl J Med. 2006 Nov 16;355(20):2149-51
17101616
J Heart Lung Transplant. 1997 May;16(5):484-92
9171265
J Pharm Sci. 2007 Nov;96(11):2829-37
17979210
Circulation. 2006 Feb 7;113(5):722-31
16461845
JAMA. 2005 Sep 14;294(10):1215-23
16160130
N Engl J Med. 2004 Jan 15;350(3):221-31
14724301
Circulation. 2005 Sep 27;112(13):2002-11
16172265
Curr Pharm Des. 2008;14(21):2111-20
18691120
Catheter Cardiovasc Interv. 2005 Jan;64(1):85-90
15619311
Ann Oncol. 2006 Aug;17(8):1263-8
16740598
Circulation. 2001 Jun 12;103(23):2816-21
11401938
Clin Cardiol. 2007 Apr;30(4):165-70
17443649
J Cardiovasc Pharmacol. 2006 Dec;48(6):286-92
17204907
Stem Cells. 1993 Nov;11(6):528-35
7906583
Am J Cardiol. 1984 Jun 15;53(12):77C-81C
6233894
J Am Coll Cardiol. 2005 Jul 19;46(2):253-60
16022951
EuroIntervention. 2005 Nov;1(3):266-72
19758915
Circulation. 2006 Jan 17;113(2):273-9
16391155
Expert Rev Med Devices. 2006 Nov;3(6):731-41
17280537
N Engl J Med. 2003 Oct 2;349(14):1315-23
14523139
Herz. 2006 May;31(3):259
17431946
Hellenic J Cardiol. 2006 Jan-Feb;47(1):7-10
16532709
J Biol Chem. 1998 Feb 27;273(9):4928-36
9478937
Am J Cardiol. 2006 Aug 15;98(4):443-6
16893694
J Biomed Mater Res. 1999 Jun 5;45(3):251-7
10397983
Curr Cancer Drug Targets. 2003 Jun;3(3):193-203
12769688
J Invasive Cardiol. 2006 Feb;18(2):70-4
16446520
Am J Cardiol. 1988 Oct 1;62(10 Pt 2):3F-24F
2972185
J Cardiovasc Surg (Torino). 2006 Aug;47(4):393-7
16953158
Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1500-10
17510464
Circulation. 2001 Jun 19;103(24):2967-72
11413088
J Am Coll Cardiol. 2001 Feb;37(2):499-504
11216969
N Engl J Med. 2002 Jun 6;346(23):1773-80
12050336
Eur Cell Mater. 2003 May 20;5:1-16; discussion 16
14562275
Circulation. 2007 Feb 27;115(8):1051-8
17325255
Catheter Cardiovasc Interv. 2007 Feb 1;69(2):198-202
17195205
Circulation. 2000 May 2;101(17):2022-5
10790340
EuroIntervention. 2007 May;3(1):149-53
19737700
Circulation. 2006 Aug 22;114(8):798-806
16908773
Circulation. 2005 May 24;111(20):2617-22
15883209
J Am Coll Cardiol. 2006 Dec 19;48(12):2440-7
17174180
Am Heart Hosp J. 2007 Summer;5(3):151-4
17673856
J Biomed Mater Res. 1983 Jan;17(1):71-82
6298242
J Clin Invest. 1995 Apr;95(4):1869-76
7706494
Circulation. 2002 Nov 19;106(21):2649-51
12438288
Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):748-53
15681298
J Interv Cardiol. 2006 Oct;19(5):414-21
17020566
Cardiovasc Hematol Agents Med Chem. 2008 Apr;6(2):105-15
18473775
Circulation. 2000 Jul 25;102(4):399-404
10908211
EuroIntervention. 2005 Aug;1(2):165-72
19758898
J Interv Cardiol. 2004 Dec;17(6):391-5
15546291
Biomaterials. 2000 Dec;21(23):2335-46
11055281
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):698-703
18182491
J Vasc Interv Radiol. 2009 Mar;20(3):315-24; quiz 325
19157901
Am Heart J. 2008 Jan;155(1):128-32
18082503
N Engl J Med. 1994 Aug 25;331(8):496-501
8041414
Cardiovasc Res. 2002 Feb 1;53(2):481-6
11827699
N Engl J Med. 1987 Mar 19;316(12):701-6
2950322
Am Heart J. 2006 Jun;151(6 Suppl):S4-10
16777509
EuroIntervention. 2007 Nov;3(3):350-8
19737717
J Am Coll Cardiol. 2003 Apr 16;41(8):1283-8
12706922
J Invasive Cardiol. 2007 Apr;19(4):182-5
17404404
Circulation. 2007 Aug 7;116(6):677-82
17679629
Circulation. 2004 Feb 17;109(6):701-5
14744976
J Invasive Cardiol. 2007 Apr;19(4):E96-8
17404416
Herz. 2004 Mar;29(2):162-6
15054588
EuroIntervention. 2007 May;3(1):154-7
19737701
Dent Mater. 1998 Mar;14(2):137-41
10023203
J Eur Acad Dermatol Venereol. 2003 Sep;17(5):493-503
12941081
Circulation. 1992 Oct;86(4):1249-56
1394931
Int J Cardiol. 2008 Jan 24;123(3):353-4
17346821
JAMA. 2008 Apr 23;299(16):1903-13
18430909
N Engl J Med. 2004 Dec 23;351(26):2715-29
15616206
Circulation. 2007 Mar 20;115(11):1440-55; discussion 1455
17344324
EuroIntervention. 2006 May;2(1):45-52
19755236
Lancet. 2007 Jun 2;369(9576):1869-1875
17544767
Am J Cardiol. 2007 Jun 15;99(12):1691-7
17560877
Lancet. 2009 Mar 14;373(9667):897-910
19286089
EuroIntervention. 2007 Feb;2(4):426-34
19755281
Immunol Cell Biol. 1995 Feb;73(1):8-16
7768548
Arch Intern Med. 2000 Sep 25;160(17):2593-9
10999972
J Mater Sci Mater Med. 2002 Sep;13(9):843-8
15348548
EuroIntervention. 2007 May;3(1):67-75
19737687
Circulation. 2001 Jan 16;103(2):192-5
11208675
Clin Pharmacokinet. 1999 Feb;36(2):99-114
10092957
EuroIntervention. 2006 Nov;2(3):310-7
19755306
J Am Coll Cardiol. 2008 Jul 29;52(5):333-42
18652940
Am J Cardiol. 2007 Oct 22;100(8B):56M-61M
17950833
Lancet. 1978 Feb 4;1(8058):263
74678